Wellderly is a probiotic complex by SynBalance, specifically designed for elderly well-being.
Based on in-vitro rational and clinical trial, Wellderly provides relief from inflammatory symptoms, improves gastro-intestinal motility, restores healthy microbiota diversity and promotes body natural defenses.
A randomized, double blind, placebo control human clinical trial has involved 50 subjects which took the product for 28 days (T28) and were further evaluated after other 28 days of follow-up (T56). It was an easy to swallow delivery form containing 1B CFU/day/strain, meaning total 4B CFU/day. Patients were evaluated through a collection of daily questionnaire/ diary reporting inflammatory symptoms assessment, collection of stool , saliva samples and genomic analysis of stool for determination of microbiota composition in terms of phylum & genera (T0, T28 and T56).
Results revealed an improvement of anti-inflammatory & antioxidant activity through an increment of beta-defensin peptides during the treatment, as well as an increased salivary IgA and salivary total antioxidant capacity, showing a positive trend even after the end of the treatment (T56). In addition, a reduction of infections prevalence (either respiratory or gastrointestinal) and a shorter symptoms duration has been reported in the active group with respect to placebo.
Phylum & genera analysis showed a biodiversity restoration at gastrointestinal level, which reflects the overall positive response of the active group.
- Wellderly
Wellderly
Overview
Scientific reference(s)
Sandionigi, Anna, et al. "Effectiveness of multistrain probiotic formulation on common infectious disease symptoms and gut microbiota modulation in flu-vaccinated healthy elderly subjects." BioMed Research International 2022 (2022).
After a selection of the most performing strains according to different and complementary in-vitro models, L. plantarum - PBS067, B. lactis - BL050, B. infantis - BI221 and B. longum - BLG240 have been chosen to compose Wellderly.
The strains showed to modulate the inflammatory cascade (improvement of IL-4 and reduction of TNF-α), to increase cells anti-oxidant potential (FRAP test) enhancing also the activity of anti-oxidant enzymes (Catalase, Superoxide dismutase and Glutathione peroxidase). All these factors indeed, concur to regulate the low-grade chronic inflammation responsible for aging.
Additional info
Therapeutical area(s)
Healthy ageing
Functionality
Anti-inflammatory activity · Antioxidant · Gut permeability
Age/Gender
Elderly
Dosage form
ND
CFU/Dose
4 billion(s)